首页> 外文期刊>Spine >Osteogenic protein-1 (osteogenic protein-1/bone morphogenetic protein-7) inhibits degeneration and pain-related behavior induced by chronically compressed nucleus pulposus in the rat.
【24h】

Osteogenic protein-1 (osteogenic protein-1/bone morphogenetic protein-7) inhibits degeneration and pain-related behavior induced by chronically compressed nucleus pulposus in the rat.

机译:成骨蛋白1(osteogenic protein-1 / bone morphogenetic protein-7)抑制大鼠慢性压迫髓核诱导的变性和疼痛相关行为。

获取原文
获取原文并翻译 | 示例
           

摘要

STUDY DESIGN: To study the therapeutic efficacy of intradiscal injection of osteogenic protein-1 (OP-1) to reduce degeneration and associated discogenic pain. OBJECTIVE: To evaluate if intradiscal injection of OP-1 can reverse disc degeneration and reduce hyperalgesia, a pain-related behavior. SUMMARY OF BACKGROUND DATA: We showed that induction of hyperalgesia was higher in rats exposed to compressed nucleus pulposus (NP). It has been reported that intradiscal injection of OP-1 stimulates synthesis of proteoglycans and collagen in normal intervertebral discs. METHODS: Rats were divided into several groups. In the sham group, the rings of an Ilizarov-type apparatus were only applied to the tail without compression. In the compressed NP group, the apparatus was used to apply chronically compression to the tail. Four weeks after surgery, the NP group was subdivided into 3 groups: saline-treated and OP-1-treated, which was divided into 2 groups (i.e., the continuous compression OP-1 [COP-1] group, in which compression was continuously applied to the tail for 4 weeks after OP-1 treatment and the release compression OP-1 [ROP-1] group, in which compression was released at treatment. Either physiologic saline or OP-1 was injected into the instrumented NP. The treated NP was harvested and applied to the left lumbar nerve roots 4 weeks after injection. Hyperalgesia was measured up to 3 weeks after surgery. The degree of disc degeneration and the appearance of the extracellular matrix in the intervertebral discs were evaluated by histology. RESULTS: Mechanical hyperalgesia was observed in the sham and saline groups, but not in the OP-1 treated group. In the saline group, NP cells became spindle-shaped. In the OP-1 group, the NP cells became swollen with vacuolated cytoplasm, and the content of the extracellular matrix was markedly increased. CONCLUSION: OP-1 injection into degenerative intervertebral disc resulted in the enhancement of the extracellular matrix and the inhibition of pain-related behavior.
机译:研究设计:研究椎间盘内注射成骨蛋白1(OP-1)减轻变性和相关的椎间盘源性疼痛的疗效。目的:评估椎间盘内注射OP-1是否可以逆转椎间盘退变并减轻痛觉过敏,这是一种与疼痛有关的行为。背景数据摘要:我们显示,暴露于压缩髓核(NP)的大鼠中痛觉过敏的诱导率更高。据报道,椎间盘内注射OP-1刺激正常椎间盘中蛋白聚糖和胶原蛋白的合成。方法:将大鼠分为几组。在假手术组中,Ilizarov型器械的环仅施加在尾巴上而没有压缩。在压缩的NP组中,使用该装置对尾巴进行长期压缩。手术后四周,NP组分为3组:生理盐水治疗组和OP-1治疗组,分为2组(即连续加压OP-1 [COP-1]组,其中加压是在OP-1处理后连续施加于尾巴上4周,并释放压缩OP-1 [ROP-1]组,在处理过程中释放压缩,将生理盐水或OP-1注入已植入的NP中。注射后第4周收集治疗后的NP并应用于左腰神经根,术后3周测量痛觉过敏,并通过组织学评估椎间盘的椎间盘退变程度和细胞外基质的出现。在假手术组和生理盐水组中观察到机械性痛觉过敏,但在OP-1治疗组中未观察到机械痛觉过敏;在生理盐水组中,NP细胞呈纺锤形;在OP-1组中,NP细胞肿胀并带有空泡的细胞质,前者的内容胞质基质明显增加。结论:OP-1注射到变性椎间盘内可增强细胞外基质并抑制疼痛相关行为。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号